Anthony Robert Rees

BioVeris Corp. developed and manufactured diagnostic products. It operates as a global health care and biosecurity company that developing proprietary technologies in diagnostics and vaccinology. The firm specializes in electrochemiluminescence and immunochemistry. The company was founded in 2003 and is headquartered in Gaithersburg, MD.

F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH develops improved therapeutic antibodies and antibody fragments for cancer. It is a biopharmaceutical company dedicated to developing novel bispecific antibody products that significantly improve on the current standard of care for patients with serious diseases such as cancer. The firm's modular antibody technology allows them to rapidly discover and develop bispecific antibodies by introducing additional binding sites to the constant region of an antibody. The company was founded by Florian Ruker, Gordana Wozniak-Knopp, and Gottfried Himmler on June 12, 2006 and is headquartered in Vienna, Austria.

IGEN International, Inc. develops and markets biological testing systems that incorporate its proprietary electrochemiluminescence technology for used in drug discovery, diagnostic products development as well as food and environmental safety testing. The company was founded in 1982 and is headquartered in Gaithersburg, MD.

MIP Technologies is a biotechnology company working at the boundary of chemistry and materials science. The company develops solutions in the Separations field using proprietary Molecularly Imprinted Polymer (MIP) technology and other novel polymer chemistries. Its pipeline of solid phase extraction (SPE) phases, based on molecular imprinting and marketed under the Supelco Sigma Aldrich brand name, SupelMIP, provides clever solutions to difficult analytical extraction problems. Its custom OPUS phases which use both molecular imprinting and smart variations of conventional polymer chemistry, provide unmatched preparative and process scale separation solutions for both small molecules and peptides.

SpinChem AB engages in the development, manufacture, and sale of products for chemical synthesis. It offers SpinChem, an innovative concept for mass transfer enhancement in reactions involving solid phase reagents, encompassing several different ways of using the stirring element itself to establish a forced flow through a heterogeneous reactant or catalyst bed, which is located inside the stirrer body. The company was founded by Fredrik Almqvist and Kjell Robert Öberg in 2007 and is headquartered in Umea, Sweden.